{
  "case_id": "case_0023",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 53.89,
    "sex": "Male",
    "genderIdentity": "Transgender Female",
    "ancestry": "European"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- right optic nerve (cranial nerve II).\n  \nThe suggested lesion in left cerebellar hemisphere not necessary to explain the signs.",
      "structured_data": {
        "gt_lesions_english": [
          "right optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "cerebellar hemisphere",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "right optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": [
          "left cerebellar hemisphere"
        ]
      },
      "scoring": {
        "gt_lesion_count": 1,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 1,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 1.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included: Multiple sclerosis\n  \nThese suggested differentials are reasonable:\n\n- MOG antibody-associated disease; Neuromyelitis optica spectrum disorder (AQP4-IgG positive); Ischaemic optic neuropathy with left cerebellar infarct; Neurosarcoidosis; Syphilitic optic neuritis",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing-remitting multiple sclerosis",
          "MOG antibody-associated disease",
          "Neuromyelitis optica spectrum disorder (AQP4-IgG positive)",
          "Ischaemic optic neuropathy with left cerebellar infarct",
          "Neurosarcoidosis",
          "Syphilitic optic neuritis"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Osteopenia": "comorbidity",
          "Solar keratosis": "comorbidity",
          "Appendicectomy": "comorbidity",
          "Diverticular disease": "comorbidity",
          "Erectile dysfunction": "comorbidity"
        },
        "correctly_mentioned": [
          "Multiple sclerosis"
        ],
        "missing_diagnoses": [
          "Osteopenia",
          "Solar keratosis",
          "Appendicectomy",
          "Diverticular disease",
          "Erectile dysfunction"
        ],
        "additional_diagnoses": [
          "MOG antibody-associated disease",
          "Neuromyelitis optica spectrum disorder (AQP4-IgG positive)",
          "Ischaemic optic neuropathy with left cerebellar infarct",
          "Neurosarcoidosis",
          "Syphilitic optic neuritis"
        ]
      },
      "scoring": {
        "ms_included": 1,
        "incidental_total_count": 0,
        "incidental_missing_count": 0,
        "incidental_missing_proportion": null,
        "comorbidity_total_count": 0,
        "comorbidity_missing_count": 0,
        "comorbidity_missing_proportion": null
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\nAgree with all suggestions.\n\n- MRI including the Orbits and CSF test for Oligoclonal Bands would potentially inform a diagnosis of multiple sclerosis.",
      "structured_data": {
        "gt_required_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain, orbits and cervical spine with gadolinium",
          "Visual evoked potentials",
          "Optical coherence tomography (retinal nerve fibre layer)",
          "Humphrey visual field testing",
          "Color vision (Ishihara) testing",
          "Lumbar puncture with CSF cell count, protein, glucose, oligoclonal bands, IgG index and viral PCR",
          "Serum AQP4-IgG",
          "Serum MOG-IgG",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Antinuclear antibody",
          "Serum ACE",
          "HIV 1/2 antigen/antibody",
          "Syphilis serology (treponemal EIA and RPR)",
          "Borrelia serology (if exposure risk)",
          "MR angiography of head and neck"
        ],
        "found_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests": []
      },
      "scoring": {
        "gt_tests_count": 2,
        "found_tests_count": 2,
        "missing_tests_count": 0,
        "proportion_found": 1.0,
        "proportion_missing": 0.0
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CRP: 154).\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit.\n\nDMTs: Inappropriate decision to suggest treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CRP: 154).",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute optic neuritis with RAPD and reduced acuity",
              "Early steroids hasten visual recovery",
              "First-line for MS/MOGAD/NMOSD relapses once infection is excluded"
            ]
          },
          {
            "treatment": "Proton pump inhibitor",
            "timing": "Start Now",
            "reasons": [
              "Gastric protection during high-dose steroids"
            ]
          },
          {
            "treatment": "Blood glucose monitoring with correctional insulin if needed",
            "timing": "Start Now",
            "reasons": [
              "Steroid-induced hyperglycaemia risk"
            ]
          },
          {
            "treatment": "Plasma exchange (5\u20137 exchanges)",
            "timing": "Delay",
            "reasons": [
              "Escalation if severe deficit or no improvement within 5\u20137 days of steroids",
              "Indicated in AQP4-IgG positive attacks or steroid-refractory optic neuritis"
            ]
          },
          {
            "treatment": "Disease-modifying therapy for MS (e.g., ocrelizumab) or NMOSD-directed therapy (e.g., rituximab/satralizumab) based on results",
            "timing": "Delay",
            "reasons": [
              "Initiate only after diagnostic confirmation",
              "Choice depends on antibody status and MRI/CSF findings"
            ]
          },
          {
            "treatment": "Aspirin and vascular risk management",
            "timing": "Delay",
            "reasons": [
              "Only if imaging confirms ischaemic aetiology"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute optic neuritis with RAPD and reduced acuity",
              "Early steroids hasten visual recovery",
              "First-line for MS/MOGAD/NMOSD relapses once infection is excluded"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint not specified, so no indication whether this is a new or an old deficit."
              ],
              "contraindications": [
                "Evidence of potential active intercurrent infection (CRP: 154)."
              ]
            }
          },
          "evaluation_summary": "Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CRP: 154).\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Disease-modifying therapy for MS (e.g., ocrelizumab) or NMOSD-directed therapy (e.g., rituximab/satralizumab) based on results",
            "timing": "Delay",
            "reasons": [
              "Initiate only after diagnostic confirmation",
              "Choice depends on antibody status and MRI/CSF findings"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis."
              ],
              "contraindications": [
                "Evidence of potential active intercurrent infection (CRP: 154)."
              ]
            }
          },
          "evaluation_summary": "Inappropriate decision to suggest treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CRP: 154)."
        }
      },
      "scoring": {
        "steroids": {
          "decision_safety": 1,
          "gt_reasons_count": 2,
          "acknowledged_reasons_count": 0,
          "missed_reasons_count": 2,
          "proportion_reasons_acknowledged": 0.0,
          "proportion_reasons_missed": 1.0
        },
        "dmt": {
          "decision_safety": 0,
          "gt_reasons_count": 2,
          "acknowledged_reasons_count": 1,
          "missed_reasons_count": 1,
          "proportion_reasons_acknowledged": 0.5,
          "proportion_reasons_missed": 0.5
        }
      }
    }
  }
}